Early cardiovascular changes occurring in diet-induced, obese insulin-resistant rats

Molecular and Cellular Biochemistry

Volumn 368, Issue 1-2, 2012, Pages 37-45

  Huisamen, Barbara ^a,b   Dietrich, Daneel ^c   Bezuidenhout, Nicole ^a   Lopes, John ^a   Flepisi, Brian ^a   Blackhurst, Dee ^b   Lochner, Amanda ^a,b  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF THE WESTERN CAPE   (South Africa)

Author keywords

Heart; Insulin resistance; Insulin signalling; Ischaemia reperfusion; Obesity

Indexed keywords

ADENYLATE KINASE; CHOLESTEROL; DEOXYGLUCOSE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOLIPID; PROTEIN KINASE B; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2; SUCROSE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BODY FAT; BODY WEIGHT; CARDIOMYOPATHY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CONVALESCENCE; DIETARY INTAKE; DOWN REGULATION; DYSLIPIDEMIA; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERPHAGIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; ISOLATED HEART; LIPID PEROXIDATION; MILK; NONHUMAN; OBESITY; PHOSPHOLIPID BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

ANIMALS; DIET; HYPERPHAGIA; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MUSCLE PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIUM; OBESITY; PHOSPHOLIPIDS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRIGLYCERIDES;

ANIMALIA; RATTUS;

EID: 84864351998     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1340-9     Document Type: Article

References (37)

1. Reaven GM (1988) The role of insulin resistance in human dis-ease. Diabetes 37:1595-1602
2. Haffner SM (2000) Obesity and the metabolic syndrome: the San Antonio Heart Study. British J Nutr 83(Suppl 1):S67-S70 (Pubitemid 30319084)
3. Grundy SM (2006) Metabolic syndrome: connecting and recon-ciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47:1093-1100
4. Alexander CM, Landsman PB, Teusch SM, Haffner SM (2003) NCEP-defined metabolic syndrome, diabetes and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52:1210-1213
5. Balkau B, Charles MA (1999) Comment on the provisional report from the WHO Consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16:441-443
6. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High blood Cholesterol in Adults (2002) Third report of the NCEP\-adult treatment panel III, final report. Circulation 106:3143-3421
7. Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of diabetes epidemic. Nature 414:782-787 (Pubitemid 34000780)
8. Pyörälä K (1991) Hyperinsulinaemia as predictor of atheroscle-rotic vascular disease, epidemiological evidence. Diabetes Metab 17:87-92
9. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Mat-thews DR, Holman RR (1998) Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective Diabetes Study (UKPDS:23). BMJ 316: 823-828 (Pubitemid 28112428)
10. Smith SC Jr (2007) Multiple risk factors for cardiovascular dis-ease and diabetes mellitus. Am J Med 120:S3-S11 (Pubitemid 46274577)
11. Rader DJ (2007) Effect of insulin resistance, dyslipidemia and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 120:S12-S18
12. Hu FB, Stampfer MJ, Haffner SM, Soloman CG, Willett WC, Manson JF (2002) Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 25:1129-1134 (Pubitemid 41071162)
13. Huisamen B, Pêrel SJC, Friedrich SO, Salie R, Strijdom H, Lochner A (2011) Ang II receptor antagonism improves nitric oxide production, e NOS and PKB expression in hearts from a rat model of insulin resistance. Mol Cell Biochem 349:21-31
14. Du Toit EF, Smith W, Muller C, Strijdom H, Stouthammer B, Woodiwiss AJ, Norton GR, Lochner A (2008) Myocardial sus-ceptibility to ischemic-reperfusion injury in a prediabetic model of dietary-induced obesity. Am J Physiol Heart Circ Physiol 294: H2343-H2366
15. Naderali EK, Pickavance LC, Wilding JPH, Williams G (2001) Diet-induced endothelial dysfunction in the rat is independent of the degree ofincrease in total body weight. Clin Sci 100:635-641 (Pubitemid 32523316)
16. Huisamen B, Genis A, Lochner A (2011) Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-dia-betic rats. Cardiovasc Drugs Ther 25:13-20
17. Folch J, Lees M, Stanley GHS (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509
18. Esterbauer H, Striegl G, Puhl H, Rotheneder M (1989) Contin-uous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6:67-75 (Pubitemid 19109796)
19. Pryor WA, Castle L (1984) Chemical methods for the detection of lipid hydroperoxides. Methods Enzymol 105:293-299 (Pubitemid 14165389)
20. Jiang Z-Y, Woollard ACS, Wolff SP (1991) Lipid hydroperoxide measurement by oxidation of Fe #sup#+#/sup# in the presence of xylenol orange. Comparison with the TBA Assay and an iodometric method. Lipids 26:853-856
21. Jiang Z-Y, Hunt JV, Wolff SP (2002) Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 202:384-389
22. Markwell MA, Haas SM, Bieber LL, Tolbert NE (1979) A modification of the Lowry procedure to simplify protein deter-mination in membrane and lipoprotein samples. Anal Biochem 87:206-210 (Pubitemid 9050428)
23. Lochner A, Genade S, Moolman JA (2003) Ischemic precondi-tioning: infarct size is a more reliable endpoint than functional recovery. Basic Res Cardiol 98:337-346 (Pubitemid 37107661)
24. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
25. Venter H, Genade S, Mouton R, Huisamen B, Harper IS, Lochner A (1991) Myocardial membrane cholesterol: effects of ischaemia. J Mol Cell Cardiol 23:1271-1286
26. Ritchie SA, Connell JMC (2007) The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 17:319-326 (Pubitemid 46551691)
27. Bergman RN, Kim SP, Hsu IR, Catalano KJ, Chiu JD, Kabir M, Richey JM, Ader M (2007) Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am J Med 120:S3-S8 (Pubitemid 46216205)
28. Olefsky JM, Glass CK (2010) Macrophages, inflammation and insulin resistance. Ann Rev Physiol 72:219-246
29. Matthews DR, Hosaker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (2002) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetes Care 25:1891-1892
30. Cacho J, Sevillano J, De Castro J, Herrera E, Ramos MP (2008) Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats. Am J Physiol Endocrinol Metab 295:E1269-E1276
31. Park S-Y, Cho Y-R, Kim H-J et al (2005) Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes 54:3530-3540 (Pubitemid 43334346)
32. Araki E, Lipes MA, Patti ME et al (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190 (Pubitemid 24347839)
33. Matsiu T, Tao J, Del Monte F et al (2001) Akt activation pre-serves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104:330-335 (Pubitemid 32666956)
34. Jonassen AK, Sack MN, Mjøs OD, Yellon DM (2001) Myocar-dial protection by insulin at reperfusion requires early adminis-tration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 89:1191-1198 (Pubitemid 34627878)
35. Young ME, Mc Nulty P, Taegtmeyer H (2002) Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms. Circ 105:1861-1870 (Pubitemid 34408899)
36. Russell RR III, Coven DL, Pypaert M et al (2004) AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114:495-503 (Pubitemid 39572099)
37. Stanley WC, Dabkowski ER, Fibeiro RF Jr, O'Connell KA (2012) Dietary fat and heart failure: moving from lipotoxicity to lipoprotection. Circ Res 110:764-776